Review



agt levels  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    R&D Systems agt levels
    Agt Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/agt levels/product/R&D Systems
    Average 92 stars, based on 2 article reviews
    agt levels - by Bioz Stars, 2026-06
    92/100 stars

    Images



    Similar Products

    agt levels  (R&D Systems)
    92
    R&D Systems agt levels
    Agt Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/agt levels/product/R&D Systems
    Average 92 stars, based on 1 article reviews
    agt levels - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    angiotensinogen levels  (Cusabio)
    92
    Cusabio angiotensinogen levels
    Kidney, urine, and serum <t>angiotensinogen</t> and renal renin levels in vehicle-treated db/m mice, vehicle-treated db/db mice, and db/db mice treated with empagliflozin, atrasentan, ramipril, or their combinations. ( A ) Angiotensinogen (AGT) mRNA expression. ( B ) Urine AGT-to-creatinine ratio. ( C ) Serum AGT values. ( D ) Renin mRNA expression. ( E ) Representative kidney sections showing specific renin staining (×400 magnification). Increased juxtaglomerular cell staining (grey arrows) is observed in treatments with ramipril and or ramipril combination with empagliflozin and/or atrasentan. ( F ) Renin stained area in µm 2 . db/m : non-diabetic mice treated with vehicle. db/db : diabetic mice treated with vehicle. db/db EMP : diabetic mice treated with empagliflozin. db/db EMP + RAM : diabetic mice treated with empagliflozin and ramipril. db/db EMP + RAM + ATR : diabetic mice treated with empagliflozin, ramipril, and atrasentan. db/db ATR : diabetic mice treated with atrasentan. db/db ATR + RAM : diabetic mice treated with atrasentan and ramipril. db/db RAM : diabetic mice treated with ramipril. Factorial ANOVA main effect results are displayed next to the graph. P Diabetes : diabetes’ main effect. P EMP : empagliflozin’s main effect. P RAM : ramipril’s main effect. P ATR : atrasentan’s main effect. $ p < 0.05 vehicle-treated db/db mice vs. vehicle-treated db/m mice. * p < 0.05 any treated db/db mice compared with vehicle-treated db/db mice. φ p < 0.05 combinations of empagliflozin or atrasentan with ramipril db/db vs. ramipril db/db.
    Angiotensinogen Levels, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/angiotensinogen levels/product/Cusabio
    Average 92 stars, based on 1 article reviews
    angiotensinogen levels - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    agt plasma levels  (Merck KGaA)
    90
    Merck KGaA agt plasma levels
    Kidney, urine, and serum <t>angiotensinogen</t> and renal renin levels in vehicle-treated db/m mice, vehicle-treated db/db mice, and db/db mice treated with empagliflozin, atrasentan, ramipril, or their combinations. ( A ) Angiotensinogen (AGT) mRNA expression. ( B ) Urine AGT-to-creatinine ratio. ( C ) Serum AGT values. ( D ) Renin mRNA expression. ( E ) Representative kidney sections showing specific renin staining (×400 magnification). Increased juxtaglomerular cell staining (grey arrows) is observed in treatments with ramipril and or ramipril combination with empagliflozin and/or atrasentan. ( F ) Renin stained area in µm 2 . db/m : non-diabetic mice treated with vehicle. db/db : diabetic mice treated with vehicle. db/db EMP : diabetic mice treated with empagliflozin. db/db EMP + RAM : diabetic mice treated with empagliflozin and ramipril. db/db EMP + RAM + ATR : diabetic mice treated with empagliflozin, ramipril, and atrasentan. db/db ATR : diabetic mice treated with atrasentan. db/db ATR + RAM : diabetic mice treated with atrasentan and ramipril. db/db RAM : diabetic mice treated with ramipril. Factorial ANOVA main effect results are displayed next to the graph. P Diabetes : diabetes’ main effect. P EMP : empagliflozin’s main effect. P RAM : ramipril’s main effect. P ATR : atrasentan’s main effect. $ p < 0.05 vehicle-treated db/db mice vs. vehicle-treated db/m mice. * p < 0.05 any treated db/db mice compared with vehicle-treated db/db mice. φ p < 0.05 combinations of empagliflozin or atrasentan with ramipril db/db vs. ramipril db/db.
    Agt Plasma Levels, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/agt plasma levels/product/Merck KGaA
    Average 90 stars, based on 1 article reviews
    agt plasma levels - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    plasma agt levels  (STATA Corporation)
    99
    STATA Corporation plasma agt levels
    Kidney, urine, and serum <t>angiotensinogen</t> and renal renin levels in vehicle-treated db/m mice, vehicle-treated db/db mice, and db/db mice treated with empagliflozin, atrasentan, ramipril, or their combinations. ( A ) Angiotensinogen (AGT) mRNA expression. ( B ) Urine AGT-to-creatinine ratio. ( C ) Serum AGT values. ( D ) Renin mRNA expression. ( E ) Representative kidney sections showing specific renin staining (×400 magnification). Increased juxtaglomerular cell staining (grey arrows) is observed in treatments with ramipril and or ramipril combination with empagliflozin and/or atrasentan. ( F ) Renin stained area in µm 2 . db/m : non-diabetic mice treated with vehicle. db/db : diabetic mice treated with vehicle. db/db EMP : diabetic mice treated with empagliflozin. db/db EMP + RAM : diabetic mice treated with empagliflozin and ramipril. db/db EMP + RAM + ATR : diabetic mice treated with empagliflozin, ramipril, and atrasentan. db/db ATR : diabetic mice treated with atrasentan. db/db ATR + RAM : diabetic mice treated with atrasentan and ramipril. db/db RAM : diabetic mice treated with ramipril. Factorial ANOVA main effect results are displayed next to the graph. P Diabetes : diabetes’ main effect. P EMP : empagliflozin’s main effect. P RAM : ramipril’s main effect. P ATR : atrasentan’s main effect. $ p < 0.05 vehicle-treated db/db mice vs. vehicle-treated db/m mice. * p < 0.05 any treated db/db mice compared with vehicle-treated db/db mice. φ p < 0.05 combinations of empagliflozin or atrasentan with ramipril db/db vs. ramipril db/db.
    Plasma Agt Levels, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasma agt levels/product/STATA Corporation
    Average 99 stars, based on 1 article reviews
    plasma agt levels - by Bioz Stars, 2026-06
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Kidney, urine, and serum angiotensinogen and renal renin levels in vehicle-treated db/m mice, vehicle-treated db/db mice, and db/db mice treated with empagliflozin, atrasentan, ramipril, or their combinations. ( A ) Angiotensinogen (AGT) mRNA expression. ( B ) Urine AGT-to-creatinine ratio. ( C ) Serum AGT values. ( D ) Renin mRNA expression. ( E ) Representative kidney sections showing specific renin staining (×400 magnification). Increased juxtaglomerular cell staining (grey arrows) is observed in treatments with ramipril and or ramipril combination with empagliflozin and/or atrasentan. ( F ) Renin stained area in µm 2 . db/m : non-diabetic mice treated with vehicle. db/db : diabetic mice treated with vehicle. db/db EMP : diabetic mice treated with empagliflozin. db/db EMP + RAM : diabetic mice treated with empagliflozin and ramipril. db/db EMP + RAM + ATR : diabetic mice treated with empagliflozin, ramipril, and atrasentan. db/db ATR : diabetic mice treated with atrasentan. db/db ATR + RAM : diabetic mice treated with atrasentan and ramipril. db/db RAM : diabetic mice treated with ramipril. Factorial ANOVA main effect results are displayed next to the graph. P Diabetes : diabetes’ main effect. P EMP : empagliflozin’s main effect. P RAM : ramipril’s main effect. P ATR : atrasentan’s main effect. $ p < 0.05 vehicle-treated db/db mice vs. vehicle-treated db/m mice. * p < 0.05 any treated db/db mice compared with vehicle-treated db/db mice. φ p < 0.05 combinations of empagliflozin or atrasentan with ramipril db/db vs. ramipril db/db.

    Journal: International Journal of Molecular Sciences

    Article Title: Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice

    doi: 10.3390/ijms232112823

    Figure Lengend Snippet: Kidney, urine, and serum angiotensinogen and renal renin levels in vehicle-treated db/m mice, vehicle-treated db/db mice, and db/db mice treated with empagliflozin, atrasentan, ramipril, or their combinations. ( A ) Angiotensinogen (AGT) mRNA expression. ( B ) Urine AGT-to-creatinine ratio. ( C ) Serum AGT values. ( D ) Renin mRNA expression. ( E ) Representative kidney sections showing specific renin staining (×400 magnification). Increased juxtaglomerular cell staining (grey arrows) is observed in treatments with ramipril and or ramipril combination with empagliflozin and/or atrasentan. ( F ) Renin stained area in µm 2 . db/m : non-diabetic mice treated with vehicle. db/db : diabetic mice treated with vehicle. db/db EMP : diabetic mice treated with empagliflozin. db/db EMP + RAM : diabetic mice treated with empagliflozin and ramipril. db/db EMP + RAM + ATR : diabetic mice treated with empagliflozin, ramipril, and atrasentan. db/db ATR : diabetic mice treated with atrasentan. db/db ATR + RAM : diabetic mice treated with atrasentan and ramipril. db/db RAM : diabetic mice treated with ramipril. Factorial ANOVA main effect results are displayed next to the graph. P Diabetes : diabetes’ main effect. P EMP : empagliflozin’s main effect. P RAM : ramipril’s main effect. P ATR : atrasentan’s main effect. $ p < 0.05 vehicle-treated db/db mice vs. vehicle-treated db/m mice. * p < 0.05 any treated db/db mice compared with vehicle-treated db/db mice. φ p < 0.05 combinations of empagliflozin or atrasentan with ramipril db/db vs. ramipril db/db.

    Article Snippet: Angiotensinogen levels were assessed in urine and serum after treatments using a commercial ELISA kit (Mouse angiotensinogen (aGT) ELISA Kit, CSB-E08566m, Cusabio, Houston, TX, USA) following manufacturer instructions.

    Techniques: Expressing, Staining